RAPID ART program yields clinical benefits in San Francisco
REPORTING FROM CROI
He acknowledged that the analysis did not address the important question of durability of virologic suppression.
The San Francisco Getting to Zero Consortium is sponsored by Gilead, Janssen, Bristol-Myers Squibb, the City of San Francisco, and by Will Hagerty. Dr. Bacon reported no conflicts of interest to disclose.
SOURCE: Buchbinder SP et al. CROI 2018, Abstract 87.